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Abstract
Over the past decade, several large epidemiologic investigations of meat intake and prostate cancer have been
published. Therefore, a meta-analysis of prospective studies was conducted to estimate potential associations
between red or processed meat intake and prostate cancer. Fifteen studies of red meat and 11 studies of
processed meat were included in the analyses. High vs. low intake and dose-response analyses were conducted
using random effects models to generate summary relative risk estimates (SRRE). No association between high vs.
low red meat consumption (SRRE = 1.00, 95% CI: 0.96-1.05) or each 100 g increment of red meat (SRRE = 1.00, 95%
CI: 0.95-1.05) and total prostate cancer was observed. Similarly, no association with red meat was observed for
advanced prostate cancer (SRRE = 1.01, 95% CI: 0.94-1.09). A weakly elevated summary association between pro-
cessed meat and total prostate cancer was found (SRRE = 1.05, 95% CI: 0.99-1.12), although heterogeneity was pre-
sent, the association was attenuated in a sub-group analysis of studies that adjusted for multiple potential
confounding factors, and publication bias likely affected the summary effect. In conclusion, the results of this meta-
analysis are not supportive of an independent positive association between red or processed meat intake and
prostate cancer.
Introduction
Worldwide, prostate cancer is the second most common
cancer among men, with only lung cancer accounting
for more cancer diagnoses annually, although the inci-
d e n c eo fp r o s t a t ec a n c e rv a r i e sc o n s i d e r a b l yb yg e o -
graphic region [1]. Indeed, adopting a “Western”
lifestyle has been hypothesized as contributing to the
geographic variation in incidence rates. Studies of popu-
lations migrating to the United States (U.S.) from Japan
and China have shown that the rate of prostate cancer
increased compared to those in their native countries,
independent of early detection [2-5], suggesting that life-
style and dietary habits may contribute to the increasing
rates of disease [6-11]. In the U.S., prostate cancer is the
most commonly diagnosed cancer among men, account-
ing for approximately one-quarter of all new cancer
cases, and this malignancy ranks as the second most
common cause of cancer mortality, particularly among
black males [12].
Although diet and prostate cancer has been investi-
gated in numerous epidemiologic studies, few foods
have been identified as potentially contributing to
increasing or decreasing the risk of this malignancy.
High intake of foods containing lycopene and selenium
may decrease risk of prostate cancer while diets high in
calcium may increase risk [3,13], although the epidemio-
logic evidence is not entirely clear. Some early studies
have suggested that fat intake may be associated posi-
tively with prostate cancer [7,14,15], but recent prospec-
tive studies have reported no associations with fat
consumption [16,17].
Over the last decade, several large cohort studies of
meat intake and prostate cancer have been published,
and in a recent systematic review of dietary factors, it was
suggested that high meat consumption may increase the
risk of prostate cancer, although the authors did not
quantify the relationship [3]. In their 2007 report on diet
and cancer, the World Cancer Research Fund/American
Institute for Cancer Research concluded that there was
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suggesting that processed meat is a cause of prostate can-
cer (pg. 124),” however, their assessment was based on
only four cohort studies [13]. Their judgment for other
types of meat was “limited-no conclusion” [13]. There-
fore, to explore further the potential relation between
meat intake and prostate cancer, we conducted a meta-
analysis of prospective studies to 1) estimate the sum-
mary associations between red meat and processed meat
and total prostate cancer, 2) evaluate associations among
men with advanced disease, 3) estimate dose-response
trends, 4) evaluate potential sources of heterogeneity, and
5) assess the potential for publication bias.
Materials and methods
A PubMed search of articles published through January,
2009, was conducted to identify studies eligible for
review. The primary search string included the following
terms: prostate cancer AND (meat OR beef OR pork OR
lamb), yielding 143 articles. A supplemental search was
conducted using fat AND prostate cancer, which yielded
482 additional articles. In addition, the bibliographies of
review articles pertaining to diet and prostate cancer
were examined in an effort to identify all available litera-
ture that may not have been identified by the PubMed
search. Prospective epidemiologic studies, published in
the English language, that reported results for the asso-
ciation between red meat or processed meat consump-
tion and prostate cancer were included in this meta-
analysis. Case-control studies, ecologic assessments,
correlation studies, and other publications of aggregate-
level analyses were excluded, as were experimental ani-
mal studies and mechanistic studies. Studies that
reported only data for a broad classification of meat,
such as ‘total meat’ categories, which included poultry
or fish, were excluded. Studies were required to report
point estimates (i.e., relative risks) and measures of
variability (i.e., 95% confidence intervals) for a high cate-
gory of red or processed meat intake compared with the
lowest category of intake, or data were required to be
available for such calculations.
Qualitative information and quantitative data were
extracted from each study that met the criteria for inclu-
sion. Specifically, information was extracted pertaining
to: the year of the study, the study population (i.e., name
and nature of the cohort), geographic location of the
study, years of follow-up, methods of dietary exposure
ascertainment, red meat and processed meat dietary vari-
ables and how these variables were defined, the analytical
comparison (i.e., the exposure contrast), the number of
exposed cases, the relative risk estimates and 95% confi-
dence intervals, and the factors that were adjusted or
controlled for in the analyses. A thorough review of each
article was conducted to identify cohorts that may have
been analyzed in multiple publications. If results were
reported in multiple publications, the inclusion of data
was based on 1) the size of the study population, 2) dura-
tion of follow-up with an emphasis on the most recent
publication with the longest follow-up, 3) classification
and analytical categorization of red or processed meat,
and 4) level of control for potential confounding factors.
Random effects models were used to calculate sum-
mary relative risk estimates (SRRE), 95% confidence
intervals, and corresponding p-values for heterogeneity.
This type of model assumes that the study-specific effect
sizes come from a random distribution of effect sizes
according to a specific mean and variance [18]. Red meat
is commonly defined as beef, pork, lamb, or a combina-
tion thereof [13,19], and processed meat is generally
defined as meat made largely from pork, beef, or poultry
that undergoes methods of preservation, such as curing,
smoking, or drying [13,19]. The definitions of red meat
and processed meat varied across studies; while some
studies explicitly defined these classifications other stu-
dies reported no description. Most studies reported data
for variables labeled as ‘red meat,’‘ processed’ or ‘pre-
served’ meat, although some studies reported data for
single meat items, such as beef, pork, liver, or bacon.
Meta-analysis models were created for high vs. low red
meat and processed meat intake. In addition to high vs.
low intake analyses, categorical dose-response regression
meta-analyses were conducted using the method pro-
posed by Greenland and Longnecker [20], in which the
linear dose-response slope is calculated for each study
while accounting for the correlation across intake cate-
gories within a study [21]. If the number of cases and
person-time data were not available for each intake
strata, variance weighted least squares regression was uti-
lized to estimate the slope coefficient. Different intake
units were reported across studies; therefore, we used
100 grams as the approximate serving size for red meat
and 50 grams for processed meat. Sensitivity analyses
were conducted for a variety of methodological quality
factors, such as level of adjustment for confounding fac-
tors, specification of red/pro c e s s e dm e a tv a r i a b l e ,a n d
number of food items ascertained in the FFQ.
Publication bias was assessed by generating funnel
plots for a visual examination, conducting correlation
and regression tests for significance, and using a ‘trim
and fill’ procedure to evaluate symmetry around the
summary effect [18]. All analyses were performed using
STATA [22] and Comprehensive Meta-Analysis [23].
Summary of cohort studies of red meat and prostate
cancer
The characteristics and findings of the prospective stu-
dies of red and processed meat and prostate cancer are
summarized below and in Table 1.
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Author and Year Cohort Exposure Variable (Definition) Number
of
Exposed
Cases
Analytical
Comparison
Relative Risk
Estimate
a
(95% CI)
Statistical Adjustment
Allen et al. 2008 European
Prospective
Investigation into
Cancer and
Nutrition (EPIC)
Red meat 371 5
th quintile vs. 1
(median intake =
90 g/day)
0.96 (0.82-1.12) Stratified by center and adjusted for education,
marital status, height, weight and energy intake
Processed meat 590 5
th quintile vs. 1
(median intake =
88 g/day)
0.93 (0.79-1.09)
Allen et al. 2004 Hiroshima and
Nagasaki, Japan
Pork 8 Almost daily vs.
<2 times/wk
1.24 (0.61-2.54) Age, calendar period, city of residence, radiation
dose, and education level
Chan et al. 2000 ATBC Study
(Finland)
Red meat NR Quintiles of intake:
5 vs. 1
0.7 (0.5-1.1) Supplementation, education, and quintiles of age,
BMI, energy and smoking
Cross et al. 2007 NIH-AARP Diet &
Health Study
Red meat (all types of beef, pork, and lamb;
including bacon, beef, cold cuts, ham, hamburger,
hot dogs, liver, pork, sausage, and steak; meats
added to mixtures, such as pizza, chili, lasagna, and
stew)
Quintiles of intake:
5 vs. 1 62.7 g/
1000 kcal vs. 9.8
Age, sex, education, marital status, family hx of
cancer, race, BMI, smoking, frequency of vigorous
physical activity, total energy intake, alcohol intake,
and fruit and vegetable consumption
3,950 All cases 1.01 (0.96-1.07)
NR Advanced cases 1.15 (0.98-1.36)
Processed meat (bacon, red meat sausage, poultry
sausage, luncheon meats, cold cuts, ham, hot dogs,
meats added to mixtures, such as pizza, chili,
lasagna, and stew)
Quintiles of intake:
5 vs. 1 22.6 g/
1000 kcal vs. 1.6
4,196 All cases 1.02 (0.97-1.07)
NR Advanced cases 1.22 (1.05-1.43)
Cross et al. 2005 PLCO Cancer
Screening Trial
Red meat (all beef, pork, and lamb [processed &
non-processed])
Quintiles of intake:
5 vs. 1
Age, race, study center, family hx of prostate
cancer, hx of diabetes, number of screening exams
during follow-up, smoking status, physical activity,
aspirin use, BMI, and intake of total energy,
supplemental vitamin E, lycopene
NR All cases 0.91 (0.73-1.12)
NR Incident cases 0.81 (0.62-1.06)
NR Advanced cases 0.92 (0.66-1.29)
Processed meat (Ham, hot dogs, liver, cold cuts,
sausage, bacon)
Quintiles of intake
5 vs. 1
NR All cases 1.14 (0.93-1.39)
NR Incident cases 1.16 (0.91-1.50)
NR Advanced cases 1.37 (0.99-1.90)
Gann et al. 1994 * Physician’s Health
Study
Beef, pork or lamb as a main dish NR Consumption: ≥5-
6 times/wk vs. ≤1-
3 times/month
2.51 (0.93-6.74) Matched by age and smoking status
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7Table 1: Summary of cohort studies of red meat or processed meat and prostate cancer (Continued)
Hsing et al. 1990 Lutheran
Brotherhood
Society Cohort
Meat (beef, bacon, fresh pork, and smoked ham) Mortalities Intake (times/
month)
Age and tobacco use
27 >39 vs. <17 0.8 (0.5-1.3)
Koutros et al.
2008
Agricultural
Health Study
(Iowa and North
Carolina)
Quintiles of intake:
5 vs. 1
Adjusted for age, state of residence, race, family hx
of prostate cancer, and smoking status
Red meat 105 All cases 1.10 (0.85-1.43)
95 Incident cases 1.11 (0.84-1.46)
21 Advanced cases 0.89 (0.50-1.60)
Bacon/sausage 140 All cases 0.98 (0.78-1.24)
125 Incident cases 0.90 (0.70-1.15)
21 Advanced cases 0.69 (0.40-1.18)
Le Marchand et al.
1994
Hawaii Pork NR Quantile of intake
4 vs. 1 (range for
cohort 0-118 g/
wk)
1.1 (0.7-1.7) Age, ethnicity, and income
Beef Tertile of intake 3
vs. 1 (range for
cohort 210-381 g/
wk)
Age, ethnicity, and income by proportional hazards
regression
NR All cases 1.6 (1.1-2.4)
NR Diagnosis age
≤72.5 yrs
2.2 (1.2-4.1)
NR Diagnosis age
>72.5 yrs
1.4 (0.8-2.5)
NR Diagnosis age
≤72.5 yrs,
localized stage
prostate cancer
2.7 (NR)
NR Diagnosis age
>72.5 yrs,
localized stage
prostate cancer
2.0 (NR)
NR Diagnosis age
≤72.5 yrs, regional
and distant stage
prostate cancer
1.4 (NR)
NR Diagnosis age
>72.5 yrs, regional
and distant stage
prostate cancer
0.8 (NR)
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7Table 1: Summary of cohort studies of red meat or processed meat and prostate cancer (Continued)
Processed meat NR Quantiles of
intake 4 vs. 1
(range for cohort
0-129 g/wk)
1.2 (0.8-1.9)
Michaud et al.
2001
Health
Professionals
Follow-Up Study
Red meat (processed meats; bacon; hot dogs;
hamburger; beef, pork, or lamb as a sandwich,
mixed dish or main dish)
Quintiles 5 vs. 1 0.91 (0.75-1.1) Age, calories, calcium, smoking, tomato sauce,
vigorous exercise, saturated fat and alpha-linolenic
fat
315 Prostate cancer
excluding stage
A1
104 Advanced
prostate cancer
1.15 (0.80-1.7)
55 Metastatic
prostate cancer
1.50 (0.88-2.5) Also adjusted for period, in addition to covariates
above
Beef, pork or lamb (main dish) 38 Intake of 5+ vs. 0/
wk, metastatic
prostate cancer
1.35 (0.72-2.5) Age, calories, calcium, smoking, tomato sauce,
vigorous exercise, saturated and alpha linolenic fat
Intake of 2+ vs. 0/
wk,
Beef, pork or lamb (sandwich or mixed dish) 64 Metastatic
prostate cancer
0.96 (0.62-1.5)
Hamburger 68 Metastatic
prostate cancer
1.08 (0.66-1.8)
Processed meats 71 Metastatic
prostate cancer
1.39 (0.94-2.1) Age, calories, calcium, smoking, tomato sauce,
vigorous exercise, saturated fat, and alpha-linolenic
fat
Bacon 50 Metastatic
prostate cancer
1.33 (0.89-2.0)
Hot dogs 15 Metastatic
prostate cancer
0.85 (0.48-1.5)
Mills et al. 1989 Seventh Day
Adventists
Beef hamburger 43 Consumed ≥1
time/wk vs. never
1.07 (0.73-1.59) Age
Beef steak 17 0.81 (0.72-1.50)
Other beef and veal 32 1.09 (0.71-1.67)
Beef index 63 1.21 (0.83-1.75)
Neuhouser et al.
2007
CARET Red meat Quartiles of intake:
high vs. low
Age, energy intake, BMI, smoking, family hx of
prostate cancer
NR Prostate cancer 0.76-1.62§ (NR)
Park et al. 2007 Multiethnic
Cohort Study
Quintile of intake:
5 vs. 1
Red meat (beef, pork, and lamb) NR Total prostate
cancer
0.97 (0.87-1.07) Time on study, ethnicity, family hx of prostate
cancer, education, BMI, smoking status, energy
intake
NR Nonlocalized or
high-grade cancer
0.95 (0.79-1.14)
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7Table 1: Summary of cohort studies of red meat or processed meat and prostate cancer (Continued)
226 African Americans 1.05 (0.86-1.27) Time on study, family hx of prostate cancer,
education, BMI, smoking status, energy intake
109 Japanese
Americans
1.04 (0.82-1.31)
270 Latinos 0.87 (0.72-1.06)
115 Whites 0.83 (0.65-1.05)
Beef NR Total prostate
cancer
0.98 (0.88-1.08) Time on study, ethnicity, family hx of prostate
cancer, education, BMI, smoking status, energy
intake
NR Nonlocalized or
high-grade cancer
0.97 (0.81-1.16)
Pork NR Total prostate
cancer
0.97 (0.88-1.08)
NR Nonlocalized or
high-grade cancer
0.92 (0.76-1.11)
Processed meat (processed red meat and processed
poultry)
Quintile of intake:
5 vs. 1
NR Total prostate
cancer
1.01 (0.91-1.12) Time on study, ethnicity, family hx of prostate
cancer, education, BMI, smoking status, energy
intake
NR Nonlocalized or
high-grade cancer
0.92 (0.77-1.11)
373 African Americans 1.00 (0.83-1.20) Time on study, family hx of prostate cancer,
education, BMI, smoking status, energy intake
181 Japanese
Americans
1.09 (0.88-1.34)
134 Latinos 0.86 (0.69-1.08)
157 Whites 1.02 (0.82-1.27)
Rodriguez et al.
2006
Cancer Prevention
Study II
Total processed plus unprocessed red meat
(includes both processed meat and red meat)
Intake: ≥657 vs.
<246 g/wk
Age at entry, total calorie intake, BMI, education,
family hx of prostate cancer, hx of PSA testing, and
hx of diabetes
27 All prostate
cancer, Blacks
2.0 (1.0-4.2)
1,239 All prostate
cancer, Whites
1.0 (0.9-1.0)
56 Metastatic
prostate cancer,
Whites
0.8 (0.5-1.3)
Unprocessed red meat Intake: ≥423 vs.
<137 g/wk
20 All prostate
cancer, Blacks
1.7 (0.8-3.9)
1,557 All prostate
cancer, Whites
1.0 (0.9-1.1)
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7Table 1: Summary of cohort studies of red meat or processed meat and prostate cancer (Continued)
69 Metastatic
prostate cancer,
Whites
0.8 (0.5-1.2)
Processed meats (includes both cooked processed
meat and lunchmeat)
Intake ≥247 vs.
<59 g/wk
28 All prostate
cancer, Blacks
2.4 (1.2-4.9)
765 All prostate
cancer, Whites
1.0 (0.9-1.1)
37 Metastatic
prostate cancer,
Whites
1.1 (0.7-1.7)
Cooked processed meat Intake ≥165 vs.
<38 g/wk
29 All prostate
cancer, Blacks
2.7 (1.3-5.3)
369 All prostate
cancer, Whites
1.0 (0.9-1.2)
21 Metastatic
prostate cancer,
Whites
1.2 (0.7-2.1)
Lunchmeat Intake ≥56 g/wk
vs. none
29 All prostate
cancer, Blacks
1.0 (0.6-1.9)
1,845 All prostate
cancer, Whites
1.0 (1.0-1.1)
88 Metastatic
prostate cancer,
Whites
1.0 (0.7-1.5)
Rohrmann et al.
2007
CLUE II Red meat (hamburgers, beef, beef stew, pork, hot
dogs, ham/lunch meats, bacon, sausages)
Tertile of daily
consumption (3
vs. 1)
Age, energy intake, consumption of tomato
products, BMI at age 21, and intake of saturated fat
51 Total prostate
cancer
0.87 (0.59-1.32)
12 High-stage
prostate cancer
0.87 (0.39-1.93)
17 Low-stage
prostate cancer
0.60 (0.31-1.18)
Beef (beef, beef stew, pork, hot dogs, ham/lunch
meats, bacon, sausages)
Consumption: >5
vs. ≤1 times/wk
84 Total prostate
cancer
1.16 (0.74-1.81)
18 High-stage
prostate cancer
0.83 (0.36-1.92)
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7Table 1: Summary of cohort studies of red meat or processed meat and prostate cancer (Continued)
35 Low-stage
prostate cancer
1.72 (0.79-3.79)
Pork Consumption: ≥1
times/wk vs. never
39 Total prostate
cancer
1.17 (0.77-1.78)
12 High-stage
prostate cancer
1.98 (0.87-4.53)
15 Low-stage
prostate cancer
0.88 (0.46-1.70)
Processed meats Consumption : >5
vs. ≤1 times/wk
96 Total prostate
cancer
1.53 (0.98-2.39)
27 High-stage
prostate cancer
2.24 (0.90-5.59)
32 Low-stage
prostate cancer
1.30 (0.62-2.74)
Consumption : ≥1
vs. <1 times/wk
Sausages 43 Total prostate
cancer
1.16 (0.79-1.73) Age, energy intake, saturated fat intake,
consumption of tomato products, and BMI at age
21
17 High-stage
prostate cancer
2.83 (1.34-5.99)
14 Low-stage
prostate cancer
0.75 (0.39-1.44)
Bacon 74 Total prostate
cancer
1.32 (0.91-1.93)
22 High-stage
prostate cancer
2.10 (0.97-4.53)
31 Low-stage
prostate cancer
1.35 (0.74-2.44)
Ham/lunch meat 115 Total prostate
cancer
1.54 (1.01-2.33)
30 High-stage
prostate cancer
1.94 (0.82-4.56)
43 Low-stage
prostate cancer
2.00 (0.94-4.25)
Hot dogs 45 Total prostate
cancer
1.12 (0.73-1.73)
13 High-stage
prostate cancer
1.71 (0.70-4.14)
18 Low-stage
prostate cancer
0.96 (0.50-1.88)
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7Table 1: Summary of cohort studies of red meat or processed meat and prostate cancer (Continued)
Schuurman et al.
1999**
Netherlands
Cohort Study
Continuous
variables of 25 g/
day increments
Age, family hx of prostate cancer, socioeconomic
status, total fresh meat and poultry
Beef NR All tumors 1.00 (0.89-1.12)
NR Localized tumors 0.95 (0.80-1.12)
NR Advanced tumors 0.92 (0.77-1.10)
Pork NR All tumors 1.06 (0.96-1.18)
NR Localized tumors 1.16 (1.00-1.34)
NR Advanced tumors 1.06 (0.91-1.23)
Minced meat (beef and pork) NR All tumors 0.86 (0.74-1.01)
NR Localized tumors 0.84 (0.66-1.07)
NR Advanced tumors 0.90 (0.71-1.14)
Continuous
variables of 5 g/
day increments
Liver NR All tumors 0.92 (0.82-1.04)
NR Localized tumors 0.99 (0.85-1.17)
NR Advanced tumors 0.79 (0.63-0.99)
Other meat (horsemeat, lamb, mutton, and veal) NR All tumors 1.06 (0.99-1.15)
NR Localized tumors 1.04 (0.93-1.16)
NR Advanced tumors 1.09 (0.98-1.21)
Cured meat (boiled ham, bacon. Lean meat
products including smoked beef, and other sliced
cold meats)
123 Quintiles of intake
5 vs. 1 36 g/day
vs. 0
1.37 (1.00-1.89) Age, family hx of prostate cancer and
socioeconomic status
NR Continuous
variables of 15 g/
day increments
Advanced tumors
1.00 (0.88-1.14)
Severson et al.
1989
Hawaii Ham, bacon, sausage 35 ≥5/vs. ≤1 times/
wk
1.11 (0.75-1.65) Age
Wu et al. 2006 US Health
Professionals
Total red meat (hamburger, beef, lamb, and pork as
main dish; beef, lamb, & pork as main dish or mixed
dish)
Intake quintile 5
vs. 1
Age, height, smoking, family hx of prostate cancer,
race, hx of vasectomy, vigorous exercise, BMI,
alcohol intake, and total energy intake
41 Age <65 yrs old 2.12 (1.18-3.78)
72 Age ≥65 yrs old 1.21 (0.85-1.74)
Processed meats (salami, bologna, or other
processed meat sandwiches; sausage, kielbasa, hot
dogs, and bacon)
Intake quintile 5
vs. 1
34 Age <65 years old 0.85 (0.47-1.56)
79 Age ≥65 years old 1.51 (1.00-2.26)
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7In a recent analysis of the Agricultural Health Study,
which followed a cohort of 57,311 licensed pesticide
applicators from Iowa and North Carolina, Koutros et
al. [24] reported a non-significant positive association
between red meat intake and prostate cancer (RR =
1.10; 95% CI: 0.85-1.43), and a non-significant inverse
association for advanced prostate cancer was observed
(RR = 0.89; 95% CI: 0.50-1.60). In their analysis of pro-
cessed meat (i.e., bacon and sausage consumption), asso-
ciations of 0.98 (95% CI: 0.78-1.24) and 0.69 (95% CI:
0.40-1.18) were observed for total prostate cancer and
advanced prostate cancer, respectively.
In the largest study of red/processed meat and pros-
tate cancer to date, Cross and colleagues [25] analyzed
over 17,000 cases of prostate cancer from the National
Institutes of Health (NIH)-AARP (formerly the Ameri-
can Association for Retired Persons) Diet and Health
Study and observed no association between the highest
levels of red meat (RR = 1.01, 95% CI: 0.96-1.07) or pro-
cessed meat (RR = 1.02, 95% CI: 0.97-1.07) intake and
total prostate cancer. Although the risks were elevated
slightly for red meat (RR = 1.15, 95% CI = 0.98-1.36)
and processed meat intake (RR = 1.22, 95% CI = 1.05-
1.43) and advanced prostate cancer, the tests for trend
were not significant. In a recent sub-group analysis of
this cohort that focused on meat compounds and cook-
ing methods, positive associations were reported for red
meat and total (RR = 1.12, 95% CI: 1.04-1.21), advanced
(RR = 1.31, 95% CI: 1.05-1.65), and fatal (RR = 1.25,
95% CI: 0.87-1.82) prostate cancer [26]. Similar associa-
tions were observed for processed meat intake and total
(RR = 1.07, 95% CI: 1.00-1.14) and advanced (RR = 1.32,
95% CI: 1.08-1.61) prostate cancer, although an inverse
associations was reported for fatal prostate cancer (RR =
0.86, 95% CI: 0.63-1.18) [26].
In an analysis of the prospective American Cancer
Society’s (ACS) Cancer Prevention Study II (CPS II)
Nutrition Cohort, Rodriguez et al. [27] reported no sig-
nificant associations (RRs ranged between 0.7 and 1.1)
between unprocessed red meat intake or total processed
plus unprocessed red meat intake and total prostate
cancer and metastatic prostate cancer among white men
(5,028 cases). Similarly, non-significant associations (RR
range: 0.9-1.3) between processed meat, cooked pro-
cessed meat, luncheon meat and total and metastatic
prostate cancer were reported among white men. Asso-
ciations for red and processed meat were stronger
among black men; however, analyses were limited to
fewer than 30 cases at the highest meat intake cate-
gories. Among black men, the RR for the highest cate-
gory of total processed plus unprocessed red meat
intake was 2.0 (95% CI: 1.0-4.2) while the RR for unpro-
cessed red meat was 1.7 (95% CI: 0.8-3.9). Associations
were elevated significantly for the highest intake
categories of processed meat (RR = 2.4; 95% CI: 1.2-4.9)
and cooked processed meat (RR = 2.7; 95% CI: 1.3-5.3),
but not lunchmeat (RR = 1.0; 95% CI: 0.6-1.9). Because
of the small number of cases, only total prostate cancer
was analyzed for black men.
In an analysis of over 1,300 prostate cancer cases in
the multi-center Prostate, Lung, Colorectal, and Ovarian
(PLCO) Cancer Screening Trial, RRs comparing the
highest vs. lowest intake levels of red meat were below
1.0 and non-significant for all prostate cancer cases,
incident cases only, and advanced cases only (RRs =
0.91, 0.81, and 0.92, respectively) [28]. Associations
between processed meat and all prostate cancer and
incident prostate cancer were similar, and were slightly
but not significantly elevated (1.14 and 1.16, respec-
tively). For advanced prostate cancer, the RR for the
highest versus lowest quintile was 1.37 (95% CI: 0.99-
1.90), although the test for trend was not significant (p-
trend = 0.32).
In their analyses of data from the Health Professionals
Follow-Up Study, Michaud et al. [29] observed a non-sig-
nificant inverse association between red meat intake and
total prostate cancer (RR for highest versus lowest quin-
tile = 0.91; 95% CI: 0.75-1.1). In contrast, non-significant
positive associations were reported for advanced (RR =
1.15) and metastatic (RR = 1.50) prostate cancer, but no
significant trends were observed. Moreover, the authors
noted that while the risk for metastatic prostate cancer
was elevated, the association with red meat was attenu-
ated after adjusting for saturated and a-linolenic fatty
acids in addition to the other covariates in the model.
Among metastatic cases, the RRs for the highest intake
categories of processed meat, bacon, and hot dogs were
1.39 (95% CI: 0.94-2.1), 1.33 (95% CI: 0.89-2.0), and 0.85
(95% CI: 0.48-1.5), respectively. In a subsequent publica-
tion of this cohort, Wu et al. [30] evaluated dietary pat-
terns and prostate cancer, although the authors reported
data specifically for red and processed meat by age strata.
Among men < 65 years of age, the RR for total red meat
intake was 2.12 (95% CI: 1.18-3.78), and the RR for men
65 and older was 1.21(95% CI: 0.85-1.74) after adjust-
ment for a western dietary pattern and other covariates.
In contrast to the analysis of red meat, the association for
processed meat was stronger among men 65 and older
(RR = 1.51, 95% CI: 1.00-2.26) compared with men
younger than age 65 (RR = 0.85, 95% CI: 0.47-1.56).
Park et al. [17] examined the association between meat
and fat intake and prostate cancer risk in the Multiethnic
Cohort Study, which included over 80,000 men in Hawaii
and Los Angeles. Inverse associations were observed for
red meat intake and total prostate cancer (RR = 0.97, 95%
CI: 0.87-1.07) and high-grade cancer (RR = 0.95, 95% CI:
0.79-1.14). Among Whites, Latinos, Japanese Americans,
and African Americans, RRs were 0.83, 0.87, 1.04, and
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tically significant. Similar associations were observed for
processed meat intake, with RRs of 1.01 and 0.92 for total
prostate cancer and high-grade cancer, respectively.
Among ethnic groups, RRs for processed meat ranged
between 0.86 and 1.09 and were not significant.
Allen et al. [31] evaluated animal foods, protein, and
calcium among over 140,000 men in the European Pro-
spective Investigation into Cancer and Nutrition (EPIC)
cohort. Participants were followed 8.7 years, on average,
and 2,727 men were diagnosed with prostate cancer.
The authors observed decreased risks of total prostate
cancer among men in the highest consumption cate-
gories of red (HR = 0.96. 95% CI: 0.82-1.12; median
intake in highest category = 90 g/day) and processed
meat (HR = 0.93, 95% CI: 0.79-1.09; median intake in
highest category = 88 g/day) after adjustment for educa-
tion, marital status, height, weight and energy intake.
In the Netherlands Cohort Study (NLCS), Schuurman
et al. [32] reported non-significant RRs for total prostate
cancer of 1.0, 1.06, 0.86, and 0.92 for the highest intake
categories of beef, pork, minced meat (beef and pork),
and liver, respectively. The RR for pork and localized
prostate tumors was marginally significant (RR = 1.16;
95% CI: 1.00-1.34), whereas the RR for liver and
advanced prostate tumors was inverse and statistically
significant (RR = 0.79; 95% CI: 0.63-0.99). The RRs for
increasing quintiles of cured meat were 1.0 (referent
group: no consumption), 1.22, 1.50, 1.18, and 1.37,
respectively (p-trend = 0.04).
In a modestly sized study of almost 4,000 participants
from the CLUE II cohort, red and processed meat intake
was analyzed for approximately 200 cases of prostate
cancer [33]. Multivariate-adjusted RRs for red meat
intake and total prostate cancer, high-stage prostate can-
cer, and low-stage prostate cancer were below 1.0 and
not statistically significant. Conversely, non-significant
positive associations were reported for processed meat
intake, with the strongest association found among per-
sons with high-stage cancer (RR = 2.24) although this
result was based on only 27 cases. Positive associations
for total prostate cancer and high-stage prostate cancer
were reported for individual processed meat items (i.e.,
sausages, bacon, ham/lunch meat, hot dogs) with two
associations being statistically significant (RR for sau-
sages and high-stage prostate cancer = 2.83, 95% CI:
1.34-5.99; RR for ham/lunch meat and total prostate
cancer = 1.54. 95% CI: 1.01-2.33).
Chan et al. [34] evaluated associations between diet
and incidence of clinical prostate cancer (stage 2-4 dis-
ease) among 27,111 Finnish participants in the Alpha-
Tocopherol Beta-Carotene Cancer Prevention Study
(ATBC Study). Although high levels of red meat intake
were evaluated (i.e., median of 214 grams in highest
intake category), all associations were inverse across the
intake strata, with an RR of 0.7 (95% CI: 0.5-1.1) in the
highest consumption category.
In a prospective study of diet and prostate cancer
among Japanese men exposed to radiation during the
bombings of Hiroshima or Nagasaki, the association
between “almost daily” consumption of pork (versus < 2
times/week) was associated weakly and non-significantly
with risk of prostate cancer (RR = 1.24; 95% CI: 0.61-
2.54; p-trend = 0.14) [35]. No other red meat items
were evaluated in this study.
In a nested case-control study conducted within the
Physicians’ Health Study cohort [36], the RR based on
consuming beef, pork, or lamb as a main dish at least 5-
6 times per week (versus 1-3 times per month or less)
was 2.51 (95% CI: 0.93-6.74). This association is consid-
erably higher than the associations reported in the other
studies, although the confidence interval is wide, indicat-
ing imprecision in the estimate. The number of cases in
the intake categories was not reported.
Le Marchand et al. [37], in a multi-ethnic, population-
based prospective cohort study of diet and cancer in
Hawaii reported no association for pork intake but
observed a significantly elevated association for beef
intake (RR = 1.6; 95% CI: 1.1-2.4). Associations were
stronger among persons with localized disease compared
with regional or distant stage cancer. A non-significant
association for processed meat intake was observed (RR
= 1.2, 95% CI: 0.8-1.9) but no trend was apparent (p-
trend = 0.38). The authors used a 13 food-item ques-
tionnaire, thus, results may have been confounded by
energy intake or other food items. In another study con-
ducted in Hawaii [38], no significant association was
observed for intake of ham, bacon, or sausage (5+ times
per week vs. <1) (RR = 1.11, 95% CI: 0.75-1.65),
although this result was adjusted for age only.
In a cohort of 17,633 white male Lutheran Brother-
hood Insurance policy holders ("The Lutheran Brother-
hood Cohort Study”), Hsing and colleagues [39]
observed a non-significant inverse association between
red/processed meat intake and prostate cancer mortality
(RR = 0.8, 95% CI: 0.5-1.3). In an evaluation of partici-
pants in the Seventh Day Adventists cohort, Mills et al.
[40] reported non-significant associations ranging
between 0.81 and 1.21 for four beef intake variables.
Summary of Meta-Analysis Results for Red and Processed
Meat Intake and Prostate Cancer
No association between consumption (high vs. low
intake) of red meat and total prostate cancer was
observed in the meta-analysis of 15 prospective studies
(SRRE = 1.00, 95% CI: 0.96-1.05; p-value for heterogene-
ity = 0.264) (Table 2, Figure 1). The summary associa-
tion changed slightly after excluding four studies that
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beef or pork) (SRRE = 0.98, 95% CI: 0.93-1.04). Modest
effect modification was observed in the analyses by pub-
lication date; no association was found in the model
restricted to the 10 published since 2000 (SRRE = 0.99,
95% CI: 0.95-1.03) while a weakly elevated summary
association was observed in the studies published prior
to 2000 (SRRE = 1.13, 95% CI: 0.92-1.37). Sensitivity
Table 2 Summary of meta-analysis findings for red and processed meat intake and prostate cancer.
Model #
Studies
SRRE (95% CI) P-
Heterogeneity
Red Meat
Total model (includes individual red meat items) 15 1.00 (0.96-1.05) 0.264
Red meat specific variable only ("red meat” as a food group) 11 0.98 (0.93-1.04) 0.353
Studies published during 2000-2009 10 0.99 (0.95-1.03) 0.593
Studies published prior to 2000 5 1.13 (0.92-1.37) 0.108
Studies that adjusted for at least three of the following factors: energy, smoking, family history of
cancer, age, race
9 0.99 (0.95-1.03) 0.536
Le Marchand removed (13 food item questionnaire) 13 0.99 (0.95-1.03) 0.401
Gann removed (outlier study) 13 0.99 (0.95-1.04) 0.364
Advanced prostate cancer 8 1.01 (0.94-1.09) 0.657
100 g increment (total prostate cancer)* 9 1.00 (0.95-1.05) 0.007
100 g increment (advanced cancer)* 5 0.97 (0.91-1.02) 0.571
Processed Meat
Total model 11 1.05 (0.99-1.12) 0.088
Michaud removed (data for metastatic prostate cancer only) 10 1.04 (0.98-1.11) 0.113
Studies published during 2000-2009 [Note: these are also the studies that adjusted for at least three
of the following factors: energy, smoking, family history of cancer, age, race]
8 1.04 (0.97-1.11) 0.085
Studies published prior to 2000 [Note: these studies did not simultaneously adjust for three of the
above factors]
3 1.25 (1.00-1.54) 0.705
Advanced prostate cancer 8 1.10 (0.95-1.27) 0.032
30 g increment (total prostate cancer) 10 1.02 (1.00-1.04) 0.274
30 g increment (advanced cancer) 6 1.01 (0.90-1.14) 0.020
*Includes studies that reported data for a “red meat” group variable.
Figure 1 Meta-analysis of prospective studies of red meat intake and prostate cancer.
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quency questionnaire (13 items) [37] and an outlier
study (greater than two-fold association) [36] did not
alter the overall summary association (Table 2). Remov-
ing the non-U.S. studies did not modify the summary
effect (SRRE = 1.00, 95% CI: 0.95-1.06, p-value for het-
erogeneity = 0.250). Similar to the high vs. low intake
analysis, no association between each 100 g increment
of red meat and prostate cancer was observed in the
categorical dose-response regression meta-analysis
(SRRE = 1.00, 95% CI: 0.95-1.05). Meta-analysis of eight
studies of advanced prostate cancer resulted in an SRRE
of 1.01 (95% CI: 0.94-1.09) with little heterogeneity (p
for heterogeneity = 0.657). The SRRE for each 100 g
increment of red meat and advanced prostate cancer
was 0.97 (95% CI: 0.91-1.02), based on data from five
studies that reported red meat as a food group variable.
The summary effect between processed meat and total
prostate cancer was slightly elevated, although the esti-
mates across studies were variable (SRRE = 1.05, 95%
CI: 0.99-1.12; p for heterogeneity = 0.088) (Table 2, Fig-
ure 2). The summary association was modified by publi-
cation date and control for important confounding
factors, as studies published between 2000-2009 and
that adjusted simultaneously for energy intake, smoking,
family history of cancer, age, or race (note: adjustment
for at least 3 of these variables required for inclusion in
this model) was 1.04 (95% CI: 0.97-1.11). The SRRE for
the three studies published prior to 2000 and that did
not adjust simultaneously for at least three of the afore-
mentioned variables was 1.25 (95% CI: 1.00-1.54).
Michaud et al. [29] reported data only for processed
meat among metastatic cases; when this study was
removed from the overall model, the SRRE became 1.04
(95% CI: 0.98-1.11). Removal of the single non-U.S. stu-
dies did not alter the summary effect although the
model became more homogeneous (SRRE = 1.05, 95%
CI: 0.98-1.12, p-value for heterogeneity = 0.157). In the
categorical dose-response regression analysis, the SRRE
for each 30 g increment of processed meat intake was
1.02 (95% CI: 1.00-1.04). No significant association
between processed meat intake and advanced prostate
cancer was found in the meta-analysis of eight studies
(SRRE = 1.10, 95% CI; 0.95-1.27). The summary associa-
tion among advanced cases was attenuated for each 30 g
increment of processed meat intake (SRRE = 1.01, 95%
CI: 0.90-1.14).
An assessment of the funnel plot of prospective stu-
dies of red meat and prostate cancer suggested slight
publication bias (Figure 3), although statistical tests did
not confirm this. Publication bias, however, was indi-
cated in the funnel plot and statistical tests for pro-
cessed meat. Point estimates from smaller studies, with
greater variability, were more likely to be distributed on
the positive side of the mean effect size (Figure 4).
Furthermore, Egger’s regression test was statistically sig-
nificant (p = 0.013) and Duval and Tweedie’st r i ma n d
fill procedure imputed four studies to the left of the
mean effect, resulting in an adjusted SRRE of 1.02 (95%
CI: 0.94-1.10) compared with 1.05 (95% CI: 0.99-1.12)
from the overall model.
Discussion
With the exception of increasing age, African-American
race, and family history of prostate cancer, little is
known about the etiology of prostate cancer [2]. Studies
Figure 2 Meta-analysis of prospective studies of processed meat intake and prostate cancer.
Alexander et al. Nutrition Journal 2010, 9:50
http://www.nutritionj.com/content/9/1/50
Page 13 of 17of persons migrating to westernized countries suggest
that exogenous factors, such as adopting certain dietary
and lifestyle characteristics, may contribute to increasing
the risk of malignancy. As a result, diet has been the
f o c u so fn u m e r o u se p i d e m i o l o g i cs t u d i e so fp r o s t a t e
cancer, although findings have not been consistent. It
has been suggested that red meat or processed meat
may be responsible for increasing the risk of prostate
cancer [2,3] but findings across the collective body of
prospective cohort studies have not produced results
indicative of an independent positive association. There-
fore, we conducted a meta-analysis of prospective stu-
dies to clarify any potential relations between red meat
or processed meat and prostate cancer.
The summary associations across the meta-analysis
models of red meat intake ranged between 0.97 and
1.01, with the exception of one model (i.e., the SRRE
was 1.13 for the five studies published prior to 2000),
and none of the associations were statistically significant
(Table 2). Furthermore, there was little heterogeneity
across the red meat models. Analyses of high vs. low
red meat intake and 100 g increment dose-response
regression produced similar results; both SRREs were
1.0.
On average, summary associations for processed meat
were slightly stronger in magnitude compared with red
meat. However, greater heterogeneity was present in the
analyses of processed meat. In sub-group analyses of the
eight studies that adjusted simultaneously for at least
three potentially important confounding factors, the
SRRE was closer to the null compared with the three
s t u d i e st h a td i dn o ta d j u s tf o rt h e s ef a c t o r s( 1 . 0 4v s .
1.25). Furthermore, the three studies that were not as
fully-adjusted were published prior to the year 2000 and
were not as large as the other studies. In addition, there
was evidence of publication bias in the meta-analysis of
processed meat. Theoretically, if all relevant studies
were included in the meta-analysis, it would be expected
that the funnel plot would be symmetric (i.e., even dis-
tribution of point estimates on either side of the mean
effect), which was not the case for processed meat (Fig-
ure 4). If the funnel plot is asymmetric, and a higher
number of smaller studies are dispersed on the right
side of the summary effect, there may be additional
small studies for which processed meat data was not
reported [23]. Using the “trim and fill” method proposed
by Duval and Tweedie, these potentially missing studies
are imputed on the other side of the summary effect,
and the overall summary association is recalculated.
This method trims the asymmetric studies from the
right-hand side to identify the unbiased effect (in an
iterative procedure), and then fills the plot by re-insert-
ing the trimmed studies on the right as well as their
imputed counterparts to the left the mean effect [18,23].
In the analysis of processed meat, this method indicated
that four studies may be missing. After imputing data
Figure 3 Funnel plot of prospective studies of red meat intake and prostate cancer.
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1.05 (95% CI: 0.99-1.12) to 1.02 (95% CI: 0.94-1.10). It
should be noted; however, that this method is merely
estimating unpublished data, rather than relying upon
actual data.
The summary association for processed meat and
prostate cancer in the current assessment was relatively
similar to the summary association reported in the
aforementioned WCRF/AICR report on diet and cancer
(summary RR per serving/week = 1.11, 95% CI: 0.99-
1.25) [13]. However, their analysis included data from
only four cohorts, whereas, in the current assessment,
data from 11 prospective studies of processed meat were
analyzed. Their analysis of case-control studies produced
a summary effect estimate of 1.01 (95% CI 0.98-1.04)
per each processed meat serving/week and prostate can-
cer [13]. WCRF/AICR judged that the epidemiologic
evidence regarding processed meat intake and prostate
cancer was “limited-suggestive” and was based on sparse
and inconsistent data [13]. The epidemiologic data for
red meat and prostate cancer were not summarized in
their report.
Although an evaluation of correlates of meat con-
sumption and prostate cancer is beyond the scope of
the current assessment, a few factors thought to contri-
bute to positive associations are worth mentioning. Few
studies examined fat intake from animal sources, parti-
cularly red meat sources, and prostate cancer. Le
Marchand et al. [37] reported that intake of “high fat
animal products” was associated positively with prostate
cancer (RR = 1.6, 95% CI: 1.1-2.4), although the source
of animal fat was not limited to meat, as milk and eggs
were included with red meat, processed meat, and poul-
try. Furthermore, diet was ascertained via a small 13-
item food frequency questionnaire, thus, the authors
could not adjust for total energy intake. In a 1993 study,
Giovannucci and colleagues [7] reported that high intake
of red meat fat was associated with a greater than two-
fold risk of advanced prostate cancer (RR = 2.64, 95%
CI: 1.21-5.77). In contrast, in a recent analysis of the
European Prospective Investigation into Cancer and
Nutrition (EPIC) cohort, Crowe et al. [16] observed
inverse associations of 0.94, 0.83, and 0.84 for fat from
red and processed meat and total prostate cancer,
advanced prostate cancer, and high-grade prostate can-
cer, respectively.
Investigations of cooking practices, meat doneness,
and dietary mutagens have not produced patterns of
associations consistent with increasing the risk of pros-
tate cancer, although the available epidemiologic data
are limited to few studies. Barbequed and pan-fried
meat has been associated inversely with prostate cancer
in three large prospective studies [24,29,41]. However, in
a sub-group analysis of the aforementioned NIH-AARP
cohort, significant positive associations were reported
for grilled/barbequed meat and total and advanced
Figure 4 Funnel plot of prospective studies of processed meat intake and prostate cancer.
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Page 15 of 17prostate cancer but a non-significant inverse association
was observed for fatal prostate cancer [26]. In the same
study, no associations were observed for pan-fried,
microwaved, or broiled meat and total, advanced, or
fatal prostate cancer [26]. The relationship between
doneness of meat intake and prostate cancer has been
inconsistent as two studies reported significant positive
associations between consumption of well and very well
done meat and prostate cancer risk [24,28] , and two
studies observed no associations for well or very well
done meat and prostate cancer [17,26]. Few studies have
evaluated dietary mutagens and prostate cancer, and no
statistically significant associations have been observed
for total mutagenic activity, 2-amino-3,8-dimethylimi-
dazo[4,5-f]quinoxaline (MeIQx), 2-amino-3,4,8-trimethy-
limidazo[4,5-f]quinoxaline (DiMeIQx), or Benzo[a]
pyrene (BaP), with most RRs slightly above or below the
null value [24,28], although a marginally significant RR
of 1.28 (95% CI: 1.00-1.65) for BaP has been reported
for advanced prostate cancer [26]. A statistically signifi-
cant positive association between 2-amino-1-methyl-6-
phenylimidazo[4,5-b]pyridine (PhIP) and total prostate
cancer and incident prostate cancer was reported in one
study [28], although null or inverse associations were
observed between the highest quintile of PhIP and total,
advanced, and fatal prostate cancer in another study
[26]. The highest quintiles of heme iron, nitrite from
meat, and nitrate from meat were associated positively
and significantly with advanced prostate cancer among
participants in the NIH-AARP cohort, however, no sig-
nificant associations were observed for total or fatal
prostate cancer with the exception of heme iron and
total prostate cancer [26]. Additional studies are neces-
sary to fully evaluate any potential associations between
consumption preferences, dietary mutagens, heme iron,
nitrite/nitrate and prostate cancer.
In the current quantitative assessment of red meat and
processed meat intake and prostate cancer, data from
prospective studies were analyzed, with the majority of
data coming from large cohorts published within the
past eight years. Collectively, most meta-analysis sum-
mary associations for red and processed meat were null,
or just above or below the null value, and not statisti-
cally significant. Summary results for processed meat
were weakly elevated; however, the association across
the more recently published studies that adjusted for
key factors was attenuated and not statistically signifi-
cant. Furthermore, there was evidence of publication
bias across the cohort studies of processed meat. In con-
clusion, the results of this meta-analysis of prospective
studies do not support an independent positive associa-
tion between intake of red meat or processed meat and
prostate cancer.
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